These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8981966)
41. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Pepe G; Camacho Vanegas O; Giusti B; Brunelli T; Marcucci R; Attanasio M; Rickards O; De Stefano GF; Prisco D; Gensini GF; Abbate R Am J Hum Genet; 1998 Sep; 63(3):917-20. PubMed ID: 9718345 [No Abstract] [Full Text] [Related]
42. MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients. Noiri E; Taguchi J; Nakao A; Fujita T Diabetes Care; 2000 Feb; 23(2):260. PubMed ID: 10868846 [No Abstract] [Full Text] [Related]
43. Methylenetetrahydrofolate reductase gene and coronary artery disease. van Bockxmeer FM; Mamotte CD; Vasikaran SD; Taylor RR Circulation; 1997 Jan; 95(1):21-3. PubMed ID: 8994411 [TBL] [Abstract][Full Text] [Related]
45. Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85. Gussekloo J; Heijmans BT; Slagboom PE; Lagaay AM; Knook DL; Westendorp RG J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):535-8. PubMed ID: 10486408 [TBL] [Abstract][Full Text] [Related]
46. Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes. Vaccaro O; Ingrosso D; Rivellese A; Greco G; Riccardi G Lancet; 1997 Apr; 349(9058):1102-3. PubMed ID: 9107272 [No Abstract] [Full Text] [Related]
47. Evolution of genetic analysis strategies in coronary heart disease: a case of unnatural selection? Keavney B; Watkins H Eur Heart J; 2001 Feb; 22(4):271-3. PubMed ID: 11161941 [No Abstract] [Full Text] [Related]
48. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy. Odawara M; Yamashita K Diabetologia; 1999 May; 42(5):631-2. PubMed ID: 10333059 [No Abstract] [Full Text] [Related]
49. Reduced frequency of the thermolabile methylenetetrahydrofolate reductase genotype in the elderly. Kluijtmans LA; Whitehead AS Atherosclerosis; 1999 Oct; 146(2):395-7. PubMed ID: 10532696 [No Abstract] [Full Text] [Related]
50. Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians. Chambers JC; Ireland H; Thompson E; Reilly P; Obeid OA; Refsum H; Ueland P; Lane DA; Kooner JS Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2448-52. PubMed ID: 11073851 [TBL] [Abstract][Full Text] [Related]
51. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy. Sacchi E; Tagliabue L; Duca F; Mannucci PM Thromb Haemost; 1997 Aug; 78(2):963-4. PubMed ID: 9268207 [No Abstract] [Full Text] [Related]
53. The 1298(A-->C) mutation of methylenetetrahydrofolate reductase should be designated to the 1289 position of the gene. Donnelly JG Am J Hum Genet; 2000 Feb; 66(2):744-5. PubMed ID: 10677336 [No Abstract] [Full Text] [Related]
54. MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes. Smyth JS; Savage DA; Maxwell AP Lancet; 1999 Apr; 353(9159):1156-7. PubMed ID: 10209988 [No Abstract] [Full Text] [Related]
55. Hyperhomocyst(e)inemia, MTHFR 677C-->T polymorphism and folate status in acute coronary disease. Kelly PJ; Furie KL Thromb Haemost; 2000 Oct; 84(4):737-8. PubMed ID: 11057888 [No Abstract] [Full Text] [Related]
56. Methylenetetrahydrofolate reductase mutation and neural tube defects. Kirke PN; Mills JL; Whitehead AS; Molloy A; Scott JM Lancet; 1996 Oct; 348(9033):1037-8. PubMed ID: 8855891 [No Abstract] [Full Text] [Related]
57. Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia and occlusive retinal vascular disease in type 2 diabetic and non-diabetic subjects. Wirta V; Saransaari P; Wirta O; Rantalaiho V; Oja SS; Pasternack A; Koivula T; Lehtimäki T Clin Nephrol; 2002 Sep; 58(3):171-8. PubMed ID: 12356186 [TBL] [Abstract][Full Text] [Related]
58. Relation of a common mutation in methylenetetrahydrofolate reductase to plasma homocysteine and early onset coronary artery disease. Dunn J; Title LM; Bata I; Johnstone DE; Kirkland SA; O'Neill BJ; Zayed E; MacDonald MC; Dempsey G; Nassar B Clin Biochem; 1998 Mar; 31(2):95-100. PubMed ID: 9622772 [TBL] [Abstract][Full Text] [Related]
59. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Gallagher PM; Meleady R; Shields DC; Tan KS; McMaster D; Rozen R; Evans A; Graham IM; Whitehead AS Circulation; 1996 Nov; 94(9):2154-8. PubMed ID: 8901666 [TBL] [Abstract][Full Text] [Related]
60. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Schneider JA; Rees DC; Liu YT; Clegg JB Am J Hum Genet; 1998 May; 62(5):1258-60. PubMed ID: 9545406 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]